Valuation: Camurus AB

Market Cap 43.59B 4.28B 3.9B 3.61B 3.26B 6.12B 399B 6.4B 17.29B 216B 16.04B 15.71B 684B P/E 2026 *
44.1x
P/E 2027 * 32.4x
Enterprise Value 39.05B 3.83B 3.49B 3.23B 2.92B 5.48B 358B 5.74B 15.49B 193B 14.37B 14.07B 612B EV / Sales 2026 *
13.6x
EV / Sales 2027 * 10.3x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day+0.14%
1 week+0.14%
Current month+9.96%
1 month+14.20%
3 months+17.27%
6 months+43.41%
Current year+20.13%
1 week 724.5
Extreme 724.5
750
1 month 653
Extreme 653
750
Current year 430.8
Extreme 430.8
750
1 year 430.8
Extreme 430.8
750
3 years 417.4
Extreme 417.4
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 2002-12-31
Director of Finance/CFO 57 2025-06-30
Chief Tech/Sci/R&D Officer 58 2024-12-31
Director TitleAgeSince
Director/Board Member 63 2001-12-31
Chairman 77 2014-12-31
Director/Board Member 61 2020-05-06
Date Insider Type Main position Quantity % Market Cap. Importance
8/7/26 Sell

Executive/Senior Manager

-5,800 0.0096%
2/27/26 Sell

Chief Executive Officer

55,550 0.0928%
2/27/26 Sell

Chief Executive Officer

1,500 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
+1.02%+0.14%+19.26%+65.92% 4.28B
-2.16%-5.22%+28.89%+126.37% 1,232B
-2.33%-6.24%+31.26%+77.32% 656B
-1.10%-4.06%+21.30%+104.26% 506B
-1.04%-0.67%+30.16%+68.01% 382B
-4.12%-10.13%+38.94%+28.62% 340B
-3.22%-4.14%+24.75%+51.30% 294B
-2.51%-4.49%-2.15%+31.64% 278B
-1.12%-6.09%+28.10%+65.30% 240B
-1.28%-0.82%+30.06%+119.17% 210B
Average -1.84%-2.13%+25.06%+73.79% 414B
Weighted average by Cap. -2.07%-2.67%+26.90%+86.83%

Financials

2026 *2027 *
Net sales 2.87B 282M 257M 238M 215M 404M 26.34B 422M 1.14B 14.23B 1.06B 1.04B 45.08B 3.68B 361M 329M 304M 275M 517M 33.71B 541M 1.46B 18.22B 1.35B 1.33B 57.7B
Net income 995M 97.55M 88.88M 82.27M 74.42M 140M 9.11B 146M 394M 4.92B 366M 358M 15.6B 1.35B 132M 121M 112M 101M 190M 12.37B 198M 536M 6.69B 497M 487M 21.18B
Net Debt -4.54B -445M -406M -376M -340M -637M -41.58B -667M -1.8B -22.47B -1.67B -1.64B -71.18B -5.7B -559M -510M -472M -427M -800M -52.24B -838M -2.26B -28.23B -2.1B -2.05B -89.41B
Projected Income Statement - Annual - Camurus AB
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
323
Date Price Change Volume
26-11-19 SEK 740.00 +1.02% 81,316
26-11-18 SEK 732.50 +0.41% 112,765
26-11-17 SEK 729.50 -1.42% 87,957
26-11-16 SEK 740.00 -0.67% 103,116
26-11-13 SEK 745.00 +0.81% 93,543
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Camurus AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
732.50SEK
Average target price
850.00SEK
Spread / Average Target
+16.04%
  1. Stock Market
  2. Stocks
  3. CAMX Stock